I. Kola

2.9k total citations
39 papers, 2.4k citations indexed

About

I. Kola is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, I. Kola has authored 39 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 10 papers in Public Health, Environmental and Occupational Health and 8 papers in Genetics. Recurrent topics in I. Kola's work include Down syndrome and intellectual disability research (6 papers), Ubiquitin and proteasome pathways (5 papers) and Epigenetics and DNA Methylation (4 papers). I. Kola is often cited by papers focused on Down syndrome and intellectual disability research (6 papers), Ubiquitin and proteasome pathways (5 papers) and Epigenetics and DNA Methylation (4 papers). I. Kola collaborates with scholars based in Australia, United States and United Kingdom. I. Kola's co-authors include Martin J. Tymms, Paul J. Hertzog, Judy B. de Haan, R. C. Iannello, Melanie Pritchard, Arun Seth, Ernst J. Wolvetang, Alan Trounson, John A. Hamilton and Genevieve Whitty and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

I. Kola

39 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Kola Australia 25 1.2k 540 478 376 322 39 2.4k
Jianbiao Zheng United States 21 966 0.8× 302 0.6× 315 0.7× 448 1.2× 377 1.2× 38 2.5k
Tatsuji Nomura Japan 28 1.2k 1.0× 327 0.6× 174 0.4× 464 1.2× 519 1.6× 99 2.8k
E P Chow United States 20 2.6k 2.1× 448 0.8× 465 1.0× 229 0.6× 622 1.9× 21 4.1k
Christian Schneeberger Austria 26 827 0.7× 357 0.7× 259 0.5× 392 1.0× 823 2.6× 70 2.5k
Dong Lin United States 28 1.7k 1.4× 487 0.9× 190 0.4× 207 0.6× 784 2.4× 55 3.6k
Eduardo H. Charreau Argentina 34 1.2k 1.0× 413 0.8× 322 0.7× 864 2.3× 911 2.8× 125 3.4k
Astrid Kehlen Germany 32 1.3k 1.0× 448 0.8× 194 0.4× 762 2.0× 154 0.5× 71 2.9k
Vidar Hansson Norway 34 2.0k 1.6× 501 0.9× 314 0.7× 337 0.9× 539 1.7× 110 3.5k
Barbara Walter United States 21 852 0.7× 500 0.9× 115 0.2× 280 0.7× 189 0.6× 31 1.8k
Roberta Mannucci Italy 26 1.3k 1.1× 358 0.7× 156 0.3× 217 0.6× 139 0.4× 38 2.1k

Countries citing papers authored by I. Kola

Since Specialization
Citations

This map shows the geographic impact of I. Kola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Kola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Kola more than expected).

Fields of papers citing papers by I. Kola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Kola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Kola. The network helps show where I. Kola may publish in the future.

Co-authorship network of co-authors of I. Kola

This figure shows the co-authorship network connecting the top 25 collaborators of I. Kola. A scholar is included among the top collaborators of I. Kola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Kola. I. Kola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kola, I.. (2008). The State of Innovation in Drug Development. Clinical Pharmacology & Therapeutics. 83(2). 227–230. 198 indexed citations
2.
Ricardo, Sharon D., Gonzalo Martı́nez-Rodrı́guez, I. Kola, et al.. (2004). Neonatal calyceal dilation and renal fibrosis resulting from loss of Adamts-1 in mouse kidney is due to a developmental dysgenesis. Nephrology Dialysis Transplantation. 20(2). 419–423. 28 indexed citations
3.
Owczarek, Catherine M., Matthew P. Hardy, Jun Kudoh, et al.. (2003). Detailed mapping of the ERG–ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16. Gene. 324. 65–77. 34 indexed citations
4.
Wolvetang, Ernst J., Owen Bradfield, Martin J. Tymms, et al.. (2003). The chromosome 21 transcription factor ETS2 transactivates the β-APP promoter: implications for Down syndrome. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1628(2). 105–110. 32 indexed citations
5.
Chan, David W., Trevor J. Wilson, Dakang Xu, et al.. (2003). Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1. British Journal of Cancer. 88(1). 137–145. 11 indexed citations
6.
Wolvetang, Ernst J., Owen Bradfield, Tanya Hatzistavrou, et al.. (2003). Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis. Neurobiology of Disease. 14(3). 349–356. 48 indexed citations
7.
Sanij, Elaine, Tanya Hatzistavrou, Paul J. Hertzog, I. Kola, & Ernst J. Wolvetang. (2001). Ets-2 Is Induced by Oxidative Stress and Sensitizes Cells to H2O2-Induced Apoptosis: Implications for Down's Syndrome. Biochemical and Biophysical Research Communications. 287(4). 1003–1008. 38 indexed citations
8.
Ross, Shelley, J Wong, Jeremiah J. Clifford, et al.. (2000). Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse.. PubMed. 20(17). 6431–41. 199 indexed citations
9.
Iannello, R. C., Peter J. Crack, Judy B. de Haan, & I. Kola. (1999). Oxidative stress and neural dysfunction in Down Syndrome. PubMed. 57. 257–267. 76 indexed citations
10.
Lambert, Paul F., et al.. (1997). The nfkb1 promoter is controlled by proteins of the Ets family.. Molecular Biology of the Cell. 8(2). 313–323. 19 indexed citations
11.
Thomas, Ross S., et al.. (1997). ETS1, NFκB and AP1 synergistically transactivate the human GM – CSF promoter. Oncogene. 14(23). 2845–2855. 133 indexed citations
12.
Iannello, R. C., J. Christopher Young, Sony Heru Sumarsono, Martin J. Tymms, & I. Kola. (1995). A model for understanding gene regulation during spermatogenesis: the mouse testis Pdha-2 promoter. Reproduction Fertility and Development. 7(4). 705–712. 3 indexed citations
13.
Hart, Adam H., Catherine M. Corrick, Martin J. Tymms, Paul J. Hertzog, & I. Kola. (1995). Human ERG is a proto-oncogene with mitogenic and transforming activity.. PubMed. 10(7). 1423–30. 47 indexed citations
14.
Iannello, R. C., et al.. (1994). Mouse testis Pdha-2 promoter upstream sequences confer tissue-and temporal-specific activity in transgenic mice. Reproduction Fertility and Development. 6(5). 599–604. 6 indexed citations
15.
Hertzog, Paul J., et al.. (1994). A gene on human chromosome 21 located in the region 21q22.2 to 21q22.3 encodes a factor necessary for signal transduction and antiviral response to type I interferons.. Journal of Biological Chemistry. 269(19). 14088–14093. 33 indexed citations
16.
Topol, Lilia, et al.. (1992). C-ets-1 protooncogene expression alters the growth properties of immortalized rat fibroblasts. Cancer Letters. 67(1). 71–78. 15 indexed citations
17.
Shaw, J., I. Kola, Douglas R. MacFarlane, & Alan Trounson. (1991). An association between chromosomal abnormalities in rapidly frozen 2-cell mouse embryos and the ice-forming properties of the cryoprotective solution. Reproduction. 91(1). 9–18. 52 indexed citations
18.
Sakkas, Denny, Alan Trounson, & I. Kola. (1989). In vivo cleavage rates and viability obtained for early cleavage mouse embryos in co-culture with oviduct cells. Reproduction Fertility and Development. 1(2). 127–136. 35 indexed citations
19.
Kola, I.. (1989). Molecular genetics of Down syndrome. Reproduction Fertility and Development. 1(1). 81–83. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianbiao Zheng Breakdown of academic impact, for papers by Tatsuji Nomura Breakdown of academic impact, for papers by E P Chow Breakdown of academic impact, for papers by Christian Schneeberger Breakdown of academic impact, for papers by Dong Lin Breakdown of academic impact, for papers by Eduardo H. Charreau Breakdown of academic impact, for papers by Astrid Kehlen Breakdown of academic impact, for papers by Vidar Hansson Breakdown of academic impact, for papers by Barbara Walter Breakdown of academic impact, for papers by Roberta Mannucci
Rankless by CCL
2026